Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Eden vs Ro

Two GLP-1 providers, one scoreboard. We put Eden and Ro head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 2 · Grade A−

Eden

Visit Eden Full brief →

FDA warning letter, June 2026 — issued to Eden Health International Inc. dba Eden. See the FDA's warning letter database.

vs
No. 10 · Grade B+

Ro

Visit Ro Full brief →

The verdict

Eden takes this head-to-head.

Eden scores 91 to 87 on our six-factor Brief Score — Eden now advertises compounded semaglutide and tirzepatide at recurring monthly prices without a separate membership fee; its FDA warning history remains relevant.

That doesn't make Ro a bad call — it's best for people comparing brand-name treatment and insurance navigation who can budget for medication plus ongoing membership. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
89
80
Supply Reliability
92
90
Transparency
93
80
Access Breadth
90
92
Clinical Oversight
92
90
Track Record
89
89
EdenBrief Score 91 · 87Ro

Price, coverage & the tracker

EdenRo
Brief Score91/100 (A−)87/100 (B+)
Semaglutide

$99/mo

No separate membership fee advertised.

Same recurring rate; no long-term contract advertised.

Full price details

$99/month for compounded semaglutide on the current GLP-1 program; no separate membership fee or long-term contract advertised

Wegovy pill from $149/mo + membership

$149 at 1.5 mg; $199 at 4 mg; $299 at 9/25 mg.

Membership: $39 first month, then $149/mo monthly; prepaid plans differ.

Full price details

Brand Wegovy pill from $149/mo for 1.5 mg, $199 at 4 mg, $299 at 9/25 mg, plus Ro membership: $39 first month then $149/mo on the monthly plan; prepaid care plans differ

Tirzepatide

$129/mo

No separate membership fee advertised.

Same recurring rate; no long-term contract advertised.

Full price details

$129/month for compounded tirzepatide on the current GLP-1 program; no separate membership fee or long-term contract advertised

Zepbound from $299/mo + membership

Starting 2.5 mg dose; higher-dose prices and offers differ.

Membership: $39 first month, then $149/mo monthly; prepaid plans differ.

Full price details

Brand Zepbound KwikPen from $299/mo at 2.5 mg plus Ro membership: $39 first month then $149/mo on the monthly plan; higher doses and prepaid plans differ

CoverageAll 50 statesConfirm your state and selected medication during eligibility review
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
On the trackerFallingprice fallingNewnew to the tracker, no prior reading

Eden: Current GLP-1 pages show $99/$129 each month, replacing the former separate-membership structure; confirm your selected program.

Ro: Brand-drug prices exclude Ro membership; the $39 introductory membership becomes $149 monthly unless a prepaid plan is selected.

● Not sold on either?

CoreAge Rx tops the whole ranking at 94/100.

CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.